ArticleFrontiers in cardiovascular medicine2025
The "Smart + Specialty" integrated model improves emergency efficiency and success in aortic dissection.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the impact of the integrated treatment model under the "smart + specialty" concept on the treatment success rate and adverse events in emergency patients with aortic dissection (AoD). Methods: A total of 166 patients with AoD treated at our hospital from March 2022 to April 2024 were selected and divided into two groups according to the order of treatment. The control group consisted of 81 patients treated from March 2022 to March 2023 and received routine emergency procedures, while the study group included 85 patients treated from April 2023 to April 2024 under the "smart + specialty" integrated treatment model. The treatment success rate, treatment efficiency, incidence of adverse events, and nursing satisfaction were compared between the two groups. Results: The treatment success rate in the study group was 100% (85/85), which was higher than the control group's rate of 92.59% (75/81), with a statistically significant difference ( Conclusion: The "smart + specialty" integrated treatment model can improve treatment efficiency and success rates in emergency AoD patients, reduce the risk of adverse events, and enhance family nursing satisfaction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.